Simplex Trading
NWBO

Simplex Trading’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Simplex Trading’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-58
Closed -$1K – 7256
2016
Q3 		$1K Buy
58
+2
+4% +$1 ﹤0.01% 5681
2016
Q2 		$2K Sell
56
-90
-62% -$96 ﹤0.01% 5166
2016
Q1 		$6K Buy
146
+20
+16% +$39 ﹤0.01% 4031
2015
Q4 		$2K Buy
126
+15
+14% +$72 ﹤0.01% 4740
2015
Q3 		$18K Sell
111
-94
-46% -$879 ﹤0.01% 2943
2015
Q2 		$95K Buy
205
+154
+302% +$1.35K 0.01% 1238
2015
Q1 		$12K Sell
51
-19
-27% -$128 ﹤0.01% 2845
2014
Q4 		$5K Buy
+70
New +$358 ﹤0.01% 3190

Other funds holding NWBO

Montecito Bank & Trust
Montecito Bank & Trust Santa Barbara, California $660M AUM 18.73% 1-Year Est. Return
Whalerock Point Partners
Whalerock Point Partners Providence, Rhode Island $587M AUM 29.61% 1-Year Est. Return
Mairs & Power Inc
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Glenmede Trust
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Simplex Trading's NWBO Position: Q4 2016 in Review

Simplex Trading sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 3,621 shares — an estimated $1.82K sold.

Simplex Trading first reported a position in NWBO in Q4 2014 and held it in 5 quarters. The position peaked at $18K in Q4 2014. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Simplex Trading reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Simplex Trading sold 3,621 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $1.82K.
  • Simplex Trading first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2014 and held it in 5 quarters.
  • Simplex Trading's Northwest Biotherapeutics, Inc. Common stock position peaked at $18K in Q4 2014.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.